Logo-jpe

J Prev Epidemiol. 2022;7(1): e02. doi: 10.34172/jpe.2022.02

Original

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial

Somaieh Ashrafi 1 ORCID, Seyyed Mohammad Ghaffari 1 ORCID, Hatam Boostani 1 ORCID, Somaieh Raz 2 ORCID, Negar Ebadi 3 ORCID, Zahra Ashrafi 4 ORCID, Pedram Nazari 4 * ORCID

Cited by CrossRef: 1

1- Khan K, Al Shouli R, Allakky A, Ferguson A, Khan A, Abuzainah B, Gutlapalli S, Chaudhuri D, Hamid P. Safety and Efficacy of Ondansetron and Simvastatin as Potential Adjunctive Treatment for Patients With Schizophrenia: A Systematic Review of Randomized Controlled Trials. 2023; [Crossref]
2- Khalafi M, Rostami H, Malekpour N, Behrouzian F, Boostani H. The Effectiveness of Augmenting Modafinil to Risperidone or Olanzapine for Treating Negative Symptoms in Schizophrenic Patients. Jundishapur J Chronic Dis Care. 2024;13(3) [Crossref]